|
With an unparalleled depth of expertise
in the pharmaceutical industry, the consultants in MattsonJack's Corporate
Development Services (CDS) group offer clients a unique perspective
on opportunities available for corporate growth and development.
CDS assists with:
- in- and out-licensing opportunity
identification, evaluation and negotiation
- product planning, manufacturing planning
and company acquisition planning
- implementation of creative financing
and business development options
- support of internal business development
activities
- divestitures
- representation
- co-promotion/partnering
- due diligence/valuations
MattsonJack combines experience in corporate and
business development, marketing, research and development,
market research, licensing and product management to thoroughly
evaluate and support clients' goals and expectations. In addition,
MattsonJack contacts lead to the identification of opportunities that
often are difficult or impossible for clients to uncover themselves.
MattsonJack is active worldwide supporting clients' needs through:
- in- and out-licensing of Japanese and
European products in the United States
- in- and out-licensing of U.S. products
throughout the world
- development of specific therapeutic category
alliances
- cooperative arrangements between pharmaceutical
and biotechnology sectors
- diagnostic and technology partnerships
- identification and assessment of potential
business partners
- market and sales forecasting
- term sheets/deal structuring/negotiations
- valuation of products
- specialization in Europe/Japan
Subscriptions to more than 100 daily publications,
journals and news organizations provide CDS members with details
about constantly changing corporate focuses and product opportunities
as they occur. The timeliness of this information enables
CDS to accelerate and enhance the corporate development efforts
of MattsonJack clients.
For more information on MattsonJack's Corporate
Development Services, phone 610-566-0700 or e-mail: info@mattsonjack.com.
|
